Uy Ear
Stock Analyst at Mizuho Securities
(3.96)
# 1,879
Out of 4,572 analysts
590
Total ratings
42.3%
Success rate
6.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Uy Ear
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $35 | $24.84 | +40.90% | 39 | Jul 20, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterated: Buy | $35 | $27.35 | +27.97% | 163 | Jul 15, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $65 | $52.89 | +22.90% | 59 | Jul 10, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Buy | $31 | $15.68 | +97.70% | 64 | Jul 10, 2026 | |
| RLMD Relmada Therapeutics | Maintained: Buy | $19 | $5.18 | +266.80% | 37 | Jul 10, 2026 | |
| EOLS Evolus | Reiterated: Buy | $15 | $5.98 | +150.84% | 50 | Jul 8, 2026 | |
| QURE uniQure | Reiterated: Buy | $35 → $68 | $38.97 | +74.49% | 26 | Jun 24, 2026 | |
| SLGL Sol-Gel Technologies | Initiated Coverage: Buy | $285 | $81.96 | +247.73% | 1 | Jun 24, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $57 | $62.00 | -8.06% | 11 | Jun 12, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $85 | $30.37 | +179.88% | 34 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $7.88 | +407.61% | 28 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.20 | +233.33% | 16 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $146 → $175 | $175.77 | -0.44% | 38 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.21 | n/a | 13 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.69 | n/a | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 | $3.71 | n/a | 1 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 | $30.81 | n/a | 1 | Jul 10, 2019 |
ACADIA Pharmaceuticals
Jul 20, 2026
Reiterated: Buy
Price Target: $35
Current: $24.84
Upside: +40.90%
Arcutis Biotherapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $35
Current: $27.35
Upside: +27.97%
Alkermes
Jul 10, 2026
Reiterated: Buy
Price Target: $65
Current: $52.89
Upside: +22.90%
Sarepta Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $31
Current: $15.68
Upside: +97.70%
Relmada Therapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $19
Current: $5.18
Upside: +266.80%
Evolus
Jul 8, 2026
Reiterated: Buy
Price Target: $15
Current: $5.98
Upside: +150.84%
uniQure
Jun 24, 2026
Reiterated: Buy
Price Target: $35 → $68
Current: $38.97
Upside: +74.49%
Sol-Gel Technologies
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $285
Current: $81.96
Upside: +247.73%
MBX Biosciences
Jun 12, 2026
Reiterated: Buy
Price Target: $57
Current: $62.00
Upside: -8.06%
Tectonic Therapeutic
Jun 10, 2026
Reiterated: Buy
Price Target: $85
Current: $30.37
Upside: +179.88%
Jun 9, 2026
Reiterated: Buy
Price Target: $40
Current: $7.88
Upside: +407.61%
Jun 1, 2026
Reiterated: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Dec 12, 2025
Maintained: Hold
Price Target: $146 → $175
Current: $175.77
Upside: -0.44%
Aug 18, 2023
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: n/a
Aug 11, 2023
Rated: Hold
Price Target: n/a
Current: $2.69
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: $14
Current: $3.71
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: $14
Current: $30.81
Upside: n/a